Condition

RNA Virus Infections

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 5 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials5

Recruiting0

Common interventions11

Lead sponsors shown5

Clinical trials

5 shown

Integrating Enhanced HIV PrEP Into a STI Clinic in LilongweNCT05307991 · 2022-03-09

COMPLETED

Self-Test Strategies and Linkage Incentives to Improve ART and PrEP Uptake in MenNCT04772469 · 2021-03-22

COMPLETED

Feasibility of Measuring Immune Resp, Activation in Foreskin/Mucosa in HIV-, Uncircumcised High-HIV-risk MSM, Lima PeruNCT02630082 · 2011-04-01

COMPLETED

Clinic-based ART Diagnostic EvaluationNCT01791556 · 2010-01-26

COMPLETED

Study of Interferon-Gamma in the Complex Treatment of Patients Infected With HIV and TuberculosisNCT05065905 · 2006-01-19

COMPLETED

Common interventions

Acute HIV testingDIAGNOSTIC_TEST1 Assisted partner notificationBEHAVIORAL1 CircumcisionPROCEDURE1 Flexible sigmoidoscopyPROCEDURE1 HIV-1 viral load testingOTHER1 Interferon-GammaDRUG1 PrEPDRUG1 Provision of multiple self-testsBEHAVIORAL1 Small monetary incentivesOTHER1 STI testingDEVICE1 Use of SMS/text reminders to motivate adherence to ART or PrEPBEHAVIORAL1

Leading sponsors

National Institute of Allergy and Infectious Diseases (NIAID) 1 SPP Pharmaclon Ltd. 1 University of California, San Francisco 1 University of North Carolina, Chapel Hill 1 Walter Reed Army Institute of Research (WRAIR) 1

Trial status mix

COMPLETED5

Phase mix

NA3

PHASE11

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.